These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 15562137)

  • 21. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 22. Private enterprise and public good: ethical issues in the funding of clinical research.
    Williams AH; Rowell M
    Ann R Coll Physicians Surg Can; 1999 Jun; 32(4):227-31. PubMed ID: 12385289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conflicting interests: the evolution of an issue.
    Healy D
    Monash Bioeth Rev; 2004 Oct; 23(4):8-18. PubMed ID: 15688509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results.
    Hole OP; Nitter-Hauge S; Cederkvist HR; Winther FO
    Eur J Clin Pharmacol; 2009 Mar; 65(3):315-8. PubMed ID: 19104790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can a good tree bring forth evil fruit? The funding of medical research by industry.
    Capps B
    Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others.
    Blümle A; Antes G; Schumacher M; Just H; von Elm E
    J Med Ethics; 2008 Sep; 34(9):e20. PubMed ID: 18757621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise.
    Bero L
    J Clin Epidemiol; 2008 Jul; 61(7):629-33. PubMed ID: 18538259
    [No Abstract]   [Full Text] [Related]  

  • 29. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 30. How pharmaceutical industry funding affects trial outcomes: causal structures and responses.
    Sismondo S
    Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Industry funding effect on positive results of probiotic use in the management of acute diarrhea: a systematized review.
    Saa C; Bunout D; Hirsch S
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):289-302. PubMed ID: 30557228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of selective publication on clinical research in pain.
    Rowbotham MC
    Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
    [No Abstract]   [Full Text] [Related]  

  • 34. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
    ten Cate JW; Büller HR
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1572-6. PubMed ID: 10443284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Publish or be damned.
    Vines G
    New Sci; 1997 Sep; 155(2099):53. PubMed ID: 16127834
    [No Abstract]   [Full Text] [Related]  

  • 37. Expedited industry-sponsored translational research: a seductive but hazardous cocktail?
    Marks JH
    Am J Bioeth; 2008 Mar; 8(3):56-8; discussion W1-3. PubMed ID: 18570106
    [No Abstract]   [Full Text] [Related]  

  • 38. [An ethical dilemma].
    Werkö L
    Lakartidningen; 2004 Aug; 101(32-33):2500. PubMed ID: 15346626
    [No Abstract]   [Full Text] [Related]  

  • 39. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
    Mello MM; Clarridge BR; Studdert DM
    Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
    Liss H
    Isr Med Assoc J; 2006 Jul; 8(7):451-4. PubMed ID: 16889157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.